Urticaria
Mast-cell histamine release → transient dermal weals ± angioedema
Overview
Superficial dermal swelling (weals/hives) from mast-cell histamine release, sometimes with deeper angioedema. Acute (=6 weeks; spontaneous or inducible). The hallmark is that each individual weal is fleeting and leaves no mark.
Recognise
- Transient, intensely itchy pink/white weals — each LESION lasts <24 hours and resolves with no bruising or scarring
- Angioedema (deeper swelling of lips, eyes, tongue) in some; dermographism
- Triggers: viral infection, foods, drugs (NSAIDs and opioids as direct mast-cell degranulators; ACE inhibitors for angioedema), and physical stimuli (cold, pressure, cholinergic)
Red flags
- Angioedema with airway or breathing compromise / anaphylaxis → IM adrenaline
- An individual weal lasting >24 hours, painful, or leaving bruising/staining → urticarial vasculitis (biopsy)
Differentials & how to tell them apart
Clinical image
We can't host this one — the image is DermNet's and their licence doesn't cover us republishing it. Their page for it is free to view.
Investigations
Acute spontaneous urticaria needs no investigation. Chronic → FBC, CRP/ESR, consider thyroid autoantibodies; skin biopsy if urticarial vasculitis is suspected; allergy testing only with a clear trigger.
Management
Regular non-sedating H1-antihistamine + avoidance of identified triggers
- 1Standard-dose non-sedating H1-antihistamine + avoid triggers; a short course of oral prednisolone for a severe acute flare.Gate: A weal lasting >24 hours, painful, or leaving bruising/staining is NOT ordinary urticaria → suspect urticarial vasculitis and biopsy; and angioedema compromising the airway is treated as anaphylaxis (IM adrenaline)
- 2Chronic urticaria with inadequate response → up-titrate the non-sedating antihistamine up to 4x the licensed dose.
- 3Chronic refractory disease → refer; omalizumab; ciclosporin.
Key points
ACE inhibitors cause angioedema WITHOUT weals (bradykinin-mediated) — it does not respond to antihistamines, so stop the drug. NSAIDs and opioids are common non-allergic triggers.
Monitor & prognosis
Symptom control (chronic: UAS7); response to omalizumab.
Acute urticaria is self-limiting; chronic spontaneous urticaria often remits over 1–5 years.
Source: NICE CKS Urticaria; BSACI guideline